Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 04, 2026
TickeronGET DAILY SIGNALS
Why Is UL Solutions (ULS) Stock Down -14.71% Today?

Why Is UL Solutions (ULS) Stock Down -14.71% Today?

Key Takeaways

  • UL Solutions shares plunged 14.71% to $77.66 as of midday trading Tuesday, following the release of second-quarter 2026 financial results.
  • The sell-off came despite an earnings beat — adjusted EPS of $0.59 topped the $0.51 consensus — signaling investor disappointment with forward-looking details.
  • Free cash flow margin contracted to 11.2% from 13.5% a year ago, while capex guidance was raised sharply to ~8.5% of revenue, the highest level in recent years.
  • Analyst projections pointed to a growth deceleration, with forward revenue estimates of just 4.9%, below the company's recent trajectory.
  • The decline was entirely company-specific, as the broader market rallied to record highs on easing Middle East tensions and strong earnings from industrial peers.
  • Traders are now watching whether management can deliver on margin targets amid rising compensation and acquisition-integration costs in the second half of 2026.

Opening Summary

ULS, the stock of UL Solutions Inc. — the Illinois-based testing, inspection, and certification giant founded in 1894 — suffered a dramatic intraday rout on Tuesday, tumbling 14.71% to $77.66. The prior session's close stood at $91.05 on August 3, 2026. The plunge erased billions in market value and came despite second-quarter results that beat profit expectations, as investors zeroed in on contracting free cash flow, elevated capital spending plans, and a projected slowdown in revenue growth.

Earnings Beat Overshadowed by Cash Flow and Spending Concerns

UL Solutions delivered what, on the surface, looked like a solid second quarter. Revenue rose 5.2% year-over-year to $816 million, roughly in line with Wall Street's $814.3 million estimate. Adjusted earnings per share hit $0.59, beating the $0.51 consensus by 15.7%. Adjusted EBITDA reached a quarterly record of $219 million, with margins expanding 140 basis points to 26.8% — the highest in company history. Organic revenue growth clocked in at 6.6%, led by the Industrial and Consumer segments.

Yet the market's reaction was ruthless. The primary culprit was free cash flow. The company's free cash flow margin fell to 11.2%, down from 13.5% in the same quarter a year earlier, signaling that UL Solutions was becoming less efficient at converting profits into actual cash. For a stock that entered the report trading at a lofty price-to-earnings multiple above 50 and with a 27% six-month rally, that deterioration in cash generation was enough to trigger a sharp re-rating.

Elevated Capex and Margin Pressure in the Outlook

Management reaffirmed its full-year 2026 guidance for mid-single-digit organic revenue growth and an adjusted EBITDA margin of approximately 27.0%. However, the company also raised its capital expenditure forecast to roughly 8.5% of revenue — a meaningful step up from the 6.5% level recorded in 2025 and above the long-term target range of 6% to 8%. The elevated spending reflects investments in laboratory capacity, modernization, and new testing capabilities tied to AI data centers, energy storage, and automotive electrification.

During the earnings call, analysts pressed management on whether second-half margins could hold given rising performance-based compensation expenses and integration costs associated with the planned acquisition of the Eurofins Electrical & Electronics testing business. While management expressed confidence in meeting full-year targets, the combination of higher capex, compensation headwinds, and M&A integration costs appeared to outweigh the second-quarter beat in the eyes of investors.

Growth Deceleration and Valuation Reassessment

Adding to the bearish case, forward-looking analyst estimates project revenue growth of just 4.9% over the next twelve months — a notable deceleration from the 6.8% annualized pace delivered over the prior two years. For a company that had commanded a premium valuation partly on the strength of its growth narrative, even a modest projected slowdown was enough to spark a repositioning.

The company continues to reshape its portfolio, exiting lower-margin service lines and completing the sale of its Employee Health and Safety software business. While these moves improve the quality of earnings over the long run, they also create near-term revenue headwinds, with roughly 1% of revenue expected to be lost from restructuring-related business exits in 2026. The restructuring plan is nearly complete, with only about $3 million in remaining pre-tax charges expected through early 2027, but the transition period has left investors questioning the pace of organic expansion.

Market Context and Trading Activity

The plunge in ULS shares stood in stark contrast to the broader market on Tuesday. The Dow Jones Industrial Average surged more than 780 points, while the S&P 500 opened in record territory, buoyed by easing U.S.-Iran tensions, a pullback in crude oil prices, and strong earnings from industrial heavyweights like CAT. This divergence underscores that the sell-off in UL Solutions was entirely company-driven rather than a reflection of sector or macro weakness.

Trading volume was elevated well above the daily average, reflecting intense investor repositioning following the earnings release. The stock sliced through multiple technical support levels, including its 50-day moving average, and traded at levels not seen since mid-July. With the 52-week range spanning $61.64 to $107.54, the shares are now firmly in the lower half of that band.

What Comes Next for ULS

The coming weeks will test whether UL Solutions can restore investor confidence. Management has maintained its full-year margin target of approximately 27.0%, and the secular tailwinds the company cites — energy transition, electrification, automation, and AI infrastructure — remain intact as long-term demand drivers for safety, certification, and compliance services. The Eurofins acquisition, once integrated, could strengthen the company's competitive position in electrical and electronics testing.

However, risks remain. If macroeconomic uncertainty causes customers to delay or cancel testing and certification projects, revenue growth could fall short of already-modest expectations. The elevated capex cycle, while strategically justified, will need to show tangible returns before the market is willing to re-rate the stock higher. The next major catalyst will be third-quarter results, where investors will scrutinize free cash flow recovery and margin resilience against the backdrop of rising costs.

Trending AI Robots

For traders seeking data-driven strategies in volatile markets like the one affecting ULS today, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dynamically updated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore a range of approaches suited to different market environments. Visit the Trending AI Robots page to discover which strategies are delivering results right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ULS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


ULS in +4.52% Uptrend, advancing for three consecutive days on October 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ULS advanced for three days, in 123 of 162 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on ULS as a result. In 26 of 38 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

ULS moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ULS crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

The Aroon Indicator entered an Uptrend today. In 105 of 139 cases where ULS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The 10-day RSI Indicator for ULS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 14 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ULS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

ULS broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. ULS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.511) is normal, around the industry mean (6.110). P/E Ratio (29.817) is within average values for comparable stocks, (32.833). Projected Growth (PEG Ratio) (1.318) is also within normal values, averaging (1.946). Dividend Yield (0.008) settles around the average of (0.025) among similar stocks. P/S Ratio (4.149) is also within normal values, averaging (9.907).

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ULS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 8.14B. The market cap for tickers in the group ranges from 47.27K to 89.8B. CTAS holds the highest valuation in this group at 89.8B. The lowest valued company is KUBR at 47.27K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was -3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -6%. GPN experienced the highest price growth at 22%, while YFOR experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 29%. For the same stocks of the Industry, the average monthly volume growth was 13% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 59
Price Growth Rating: 56
SMR Rating: 73
Profit Risk Rating: 82
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
ULS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry OfficeEquipmentSupplies

Industry
N/A
Address
333 Pfingsten Road
Phone
+1 847 272-8800
Employees
14851
Web
https://www.ul.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
AstraZeneca reported Q1 2026 total revenue of $15.3 billion, up 8% at constant exchange rates (CER, adjusting for currency fluctuations), beating consensus estimates around $14.8 billion. Core earnings per share (EPS) rose 5% to $2.58 at CER, amid a 12% increase in core operating profit.
Consensus estimates call for Q3 FY2026 revenue of approximately $3.37 billion, in line with the company's guidance midpoint of $3.35 billion. Non-GAAP earnings per share (EPS) expected at $9.16, edging above the guided midpoint of $9.08.